SB 227 - Currently, no evidence that a collateral source made payments to a plaintiff is admissible in court other than as provided by statute. This act specifies that no evidence of collateral sources pertaining to the cost of medical treatment shall be admissible except as provided by the act.
A defendant's payment of a plaintiff's special damages prior to trial shall not be admissible or recoverable from that defendant. A defendant who makes such payment of special damages shall not be able to receive a credit or deduction of that amount from the final judgment, unless such payments have been included in the plaintiff's claim for special damages at trial.
This act provides that the parties may introduce evidence of the cost, rather than the value, of the medical treatment rendered, and repeals a provision of law which provides that there is a rebuttal presumption that the value of the medical treatment provided is represented by the dollar amount necessary to satisfy the financial obligation to the health care provider. The cost of any medical treatment shall not exceed the dollar amount paid for by any source to satisfy the financial obligation of the health care provider for the treatment.
Evidence presented regarding medical treatment rendered shall be presented in terms of the part or projected actual cost necessary to satisfy the cost of such treatment and without reference to any billed charges in excess of such costs.
This act is similar to SB 799 (2014).